These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 2143719

  • 1. Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids.
    Stanczyk FZ, Roy S.
    Contraception; 1990 Jul; 42(1):67-96. PubMed ID: 2143719
    [Abstract] [Full Text] [Related]

  • 2. Clinical aspects of three new progestogens: desogestrel, gestodene, and norgestimate.
    Chez RA.
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1296-300. PubMed ID: 2524163
    [Abstract] [Full Text] [Related]

  • 3. Effect of the progestogens, gestodene, 3-keto desogestrel, levonorgestrel, norethisterone and norgestimate on the oxidation of ethinyloestradiol and other substrates by human liver microsomes.
    Back DJ, Houlgrave R, Tjia JF, Ward S, Orme ML.
    J Steroid Biochem Mol Biol; 1991 Feb; 38(2):219-25. PubMed ID: 2004043
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF, Crook D, Simpson R, Proudler T, Felton C, Lees B, Anyaoku V, Devenport M, Wynn V.
    N Engl J Med; 1990 Nov 15; 323(20):1375-81. PubMed ID: 2146499
    [Abstract] [Full Text] [Related]

  • 6. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V.
    Contracept Fertil Sex (Paris); 1985 Jan 15; 13(1 Suppl):425-30. PubMed ID: 12280210
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characteristics of the new progestogens in combination oral contraceptives.
    Rebar RW, Zeserson K.
    Contraception; 1991 Jul 15; 44(1):1-10. PubMed ID: 1832625
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
    Bergink W, Assendorp R, Kloosterboer L, van Lier W, Voortman G, Qvist I.
    Am J Obstet Gynecol; 1990 Dec 15; 163(6 Pt 2):2132-7. PubMed ID: 2147817
    [Abstract] [Full Text] [Related]

  • 13. Desogestrel, norgestimate, and gestodene: the newer progestins.
    Kaplan B.
    Ann Pharmacother; 1995 Dec 15; 29(7-8):736-42. PubMed ID: 8520092
    [Abstract] [Full Text] [Related]

  • 14. Comparative metabolism of 17alpha-ethynyl steroids used in oral contraceptives.
    Ranney RE.
    J Toxicol Environ Health; 1977 Sep 15; 3(1-2):139-66. PubMed ID: 411940
    [Abstract] [Full Text] [Related]

  • 15. Long-acting contraceptive agents: in vitro hydrolysis of esters of norethisterone and levonorgestrel.
    Naderi S, Fotherby K.
    Steroids; 1983 Mar 15; 41(3):397-417. PubMed ID: 6419410
    [Abstract] [Full Text] [Related]

  • 16. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
    Godsland IF, Walton C, Felton C, Proudler A, Patel A, Wynn V.
    J Clin Endocrinol Metab; 1992 Jan 15; 74(1):64-70. PubMed ID: 1530790
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic and "potency" of contraceptive steroids.
    Back DJ, Breckenridge A, Orme M, Shaw MA.
    Lancet; 1984 Jan 21; 1(8369):171. PubMed ID: 6140487
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.